Fred Alger Management, LLC Meira G Tx Holdings PLC Transaction History

Fred Alger Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$12.4 - $17.6 $364,522 - $517,387	-29,397 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$11.59 - $14.93 $78,846 - $101,568	-6,803 Reduced 18.79%	29,397 $389,000
Q2 2020 Aug 14, 2020	SELL	$11.79 - $15.97 $21,222 - $28,746	-1,800 Reduced 4.74%	36,200 $453,000
Q1 2020 May 15, 2020	BUY	$9.31 - $21.24 $18,620 - $42,480	2,000 Added 5.56%	38,000 $511,000
Q4 2019 Feb 14, 2020	BUY	$13.91 - $21.48 $69,550 - $107,400	5,000 Added 16.13%	36,000 $721,000
Q3 2019 Nov 14, 2019	BUY	$15.84 - $30.01 $205,920 - $390,130	13,000 Added 72.22%	31,000 $494,000
Q2 2019 Aug 14, 2019	BUY	$17.38 - $26.88 $139,040 - $215,040	8,000 Added 80.0%	18,000 $484,000
Q1 2019 May 14, 2019	BUY	$9.2 - $21.21 $92,000 - $212,100	10,000 New	10,000 $172,000

101

45.4M

19.2K

31K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $279M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.